Back to Search Start Over

Revising model for end-stage liver disease from calendar-time cross-sections with correction for selection bias.

Authors :
de Ferrante HC
van Rosmalen M
Smeulders BML
Vogelaar S
Spieksma FCR
Source :
BMC medical research methodology [BMC Med Res Methodol] 2024 Feb 28; Vol. 24 (1), pp. 51. Date of Electronic Publication: 2024 Feb 28.
Publication Year :
2024

Abstract

Background: Eurotransplant liver transplant candidates are prioritized by Model for End-stage Liver Disease (MELD), a 90-day waitlist survival risk score based on the INR, creatinine and bilirubin. Several studies revised the original MELD score, UNOS-MELD, with transplant candidate data by modelling 90-day waitlist mortality from waitlist registration, censoring patients at delisting or transplantation. This approach ignores biomarkers reported after registration, and ignores informative censoring by transplantation and delisting.<br />Methods: We study how MELD revision is affected by revision from calendar-time cross-sections and correction for informative censoring with inverse probability censoring weighting (IPCW). For this, we revised UNOS-MELD on patients with chronic liver cirrhosis on the Eurotransplant waitlist between 2007 and 2019 (n = 13,274) with Cox models with as endpoints 90-day survival (a) from registration and (b) from weekly drawn calendar-time cross-sections. We refer to the revised score from cross-section with IPCW as DynReMELD, and compare DynReMELD to UNOS-MELD and ReMELD, a prior revision of UNOS-MELD for Eurotransplant, in geographical validation.<br />Results: Revising MELD from calendar-time cross-sections leads to significantly different MELD coefficients. IPCW increases estimates of absolute 90-day waitlist mortality risks by approximately 10 percentage points. DynReMELD has improved discrimination over UNOS-MELD (delta c-index: 0.0040, p < 0.001) and ReMELD (delta c-index: 0.0015, p < 0.01), with differences comparable in magnitude to the addition of an extra biomarker to MELD (delta c-index: ± 0.0030).<br />Conclusion: Correcting for selection bias by transplantation/delisting does not improve discrimination of revised MELD scores, but substantially increases estimated absolute 90-day mortality risks. Revision from cross-section uses waitlist data more efficiently, and improves discrimination compared to revision of MELD exclusively based on information available at listing.<br /> (© 2024. The Author(s).)

Details

Language :
English
ISSN :
1471-2288
Volume :
24
Issue :
1
Database :
MEDLINE
Journal :
BMC medical research methodology
Publication Type :
Academic Journal
Accession number :
38419019
Full Text :
https://doi.org/10.1186/s12874-024-02176-8